Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medsep Corporation is a medical technology company specializing in the development and manufacture of blood collection, separation, and filtration systems. Originally a division of Baxter International, the company was acquired by Pall Corporation in 1997 and subsequently sold to Haemonetics Corporation in 2012 for $550 million. Medsep is widely recognized for its advanced leukoreduction filters and blood bag systems, which are essential for removing white blood cells from donated blood to prevent transfusion-related complications. The company's manufacturing operations, historically located in Covina, California, and Fajardo, Puerto Rico, support the global supply of blood processing components. Today, Medsep's technologies are fully integrated into the Haemonetics portfolio, serving blood centers and hospitals worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medsep Corporation.